Standout Papers

The Development of Human Benign Prostatic Hyperplasia with Age 1982 2026 1996 2011 1.8k
  1. The Development of Human Benign Prostatic Hyperplasia with Age (1984)
    Stephen J. Berry, Donald S. Coffey et al. The Journal of Urology
  2. Risk of Prostate Cancer–Specific Mortality Following Biochemical Recurrence After Radical Prostatectomy (2005)
    Stephen J. Freedland, Elizabeth B. Humphreys et al. JAMA
  3. Impotence Following Radical Prostatectomy: Insight Into Etiology and Prevention (1982)
    Patrick C. Walsh, P.J. Donker The Journal of Urology
  4. Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease (1998)
    William J. Catalona, Alan W. Partin et al. JAMA
  5. LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY (2001)
    Misop Han, Alan W. Partin et al. Urologic Clinics of North America
  6. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium (2001)
    Alan W. Partin, Leslie A. Mangold et al. Urology
  7. Radical prostatectomy with preservation of sexual function: Anatomical and pathological considerations (1983)
    Patrick C. Walsh, Herbert Lepor et al. The Prostate
  8. Correlation of pathologic findings with progression after radical retropubic prostatectomy (1993)
    Jonathan I. Epstein, Galina Pizov et al. Cancer
  9. Biochemical (Prostate Specific Antigen) Recurrence Probability Following Radical Prostatectomy for Clinically Localized Prostate Cancer (2003)
    Misop Han, Alan W. Partin et al. The Journal of Urology
  10. Cancer Control and Quality of Life Following Anatomical Radical Retropubic Prostatectomy: Results at 10 Years (1994)
    Patrick C. Walsh, Alan W. Partin et al. The Journal of Urology
  11. Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign Hyperplasia (1990)
    Alan W. Partin, H. Ballentine Carter et al. The Journal of Urology
  12. Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience (2011)
    Jeffrey J. Tosoian, Bruce J. Trock et al. Journal of Clinical Oncology
  13. Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical Prostatectomy (1988)
    Joseph E. Oesterling, Daniel W. Chan et al. The Journal of Urology
  14. Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. (1993)
    Alan W. Partin, Charles R. Pound et al. PubMed
  15. Familial Incomplete Male Pseudohermaphroditism, Type 2 (1974)
    Patrick C. Walsh, James D. Madden et al. New England Journal of Medicine
  16. Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy (2011)
    Scott E. Eggener, Peter T. Scardino et al. The Journal of Urology
  17. Family history and the risk of prostate cancer (1990)
    Gary D. Steinberg, Bob S. Carter et al. The Prostate
  18. Prediction of Progression Following Radical Prostatectomy (1996)
    Jonathan I. Epstein, Alan W. Partin et al. The American Journal of Surgical Pathology
  19. Prognostic G leason grade grouping: data based on the modified G leason scoring system (2013)
    Phillip M. Pierorazio, Patrick C. Walsh et al. British Journal of Urology
  20. The induction of prostatic hypertrophy in the dog with androstanediol. (1976)
    Patrick C. Walsh, Jean D. Wilson Journal of Clinical Investigation
  21. Precise Localization of the Autonomic Nerves From the pelvic Plexus to the Corpora Cavernosa: a Detailed Anatomical Study of the Adult Male Pelvis (1985)
    Herbert Lepor, Ranice W. Crosby et al. The Journal of Urology

Immediate Impact

4 by Nobel laureates 6 from Science/Nature 92 standout
Sub-graph 1 of 15

Citing Papers

Prostate Cancer
2025 Standout
Pan-cancer whole-genome comparison of primary and metastatic solid tumours
2023 StandoutNature
38 intermediate papers

Works of Patrick C. Walsh being referenced

Standard Versus Age-Specific Prostate Specific Antigen Reference Ranges Among Men With Clinically Localized Prostate Cancer: A Pathological Analysis
1996
Implication of cell kinetic changes during the progression of human prostatic cancer.
1995
and 46 more

Author Peers

Author Last Decade Papers Cites
Patrick C. Walsh 28931 9236 7799 576 39.8k
Peter T. Scardino 39907 10430 9899 737 50.9k
Alan W. Partin 30367 7759 6273 643 39.3k
Peter R. Carroll 30126 6099 9987 870 44.9k
Teuvo L.J. Tammela 12416 3029 3623 658 23.7k
Jonathan I. Epstein 45885 16383 15480 977 62.0k
David G. Bostwick 15885 6062 5537 455 26.6k
William J. Catàlona 20368 6546 7554 528 30.1k
Theodorus van der Kwast 21602 4942 8092 647 34.4k
Eric A. Klein 19268 3444 5867 722 29.1k
Francesco Montorsi 32046 11052 17503 1.7k 57.7k

All Works

Loading papers...

Rankless by CCL
2026